HIV-Peplotion Vaccine: A Novel Approach to Vaccination against AIDS by Transepithelial Transport of Viral Peptides and Antigens to Langerhans Cells for Induction of Cytolytic T Cells by HLA Class I and CD1 Molecules for Long Term Protection

Advances in Experimental Medicine and Biology

Volumn 397, Issue , 1996, Pages 97-104

  Becker, Yechiel ^a,b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b European Network Man Against Virus

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN PRESENTATION; CELL PROTECTION; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; GENE INDUCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LANGERHANS CELL; PRIORITY JOURNAL; VACCINATION; VIRUS REPLICATION;

EID: 0030024553     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4899-1382-1_14     Document Type: Article

References (22)

1. Becker, Y., 1993, From the discovery of poliovirus vaccinia virus mRNAs and polyribosomes to computer analysis of HIV-1 and 2 glycoproteins, in Concepts in Virology (B.W.J. Mahy and D.K. Lvov, editors) pp 77-79, Hardwood Academic Publishers.
2. Becker, Y., 1994a, HIV-1 proteins in infected cells determine the presentation of viral peptides by HLA class I and class II molecules and the nature of the cellular and humoral antiviral immune responses - a review, Virus Genes, 8:249-270.
3. + CTLs - an approach to immunization of humans, Virus Genes, 9: 133-147.
4. Becker, Y., 1995, Computer simulations to predict the availability of peptides with known HLA class I motifs possibly generated by proteolysis of HIV-1 proteins in infected cells, Virus Genes 10:in press.
5. + T cells, Nature, 37: 691-694.
6. Bjorkman, P.J., Saper, M.A., Samaraoni, B., Bennet, W.S., Strominger, J.L., and Wiley, D.C., 1987, The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens, Nature 329:512-518, 1987.
7. Bolognesi, D., 1994, Not Yet, it is too early to use a live attenuated virus vaccine against HIV-1, J. NIH Res. 6:55, 59-62.
8. Cameron, P.U., Mallal, S.A., French, M.A.H., and Dawkins, R.L. 1990, Central MHC genes between HLA-B and complement C4 confer risk for HIV-1 disease progression, Human Immunology 29:282-295.
9. Choi, H.K., Flynn, G.L., and Amidon, G.G., 1994, Transdermal delivery of bioactive peptides: the effect of n-decylmethyl solfoxide, pH and inhibitors of enkephalin metabolism and transport, Pharm. Res. 7:1099-1106, 1990.
10. Desrosiers, R.C., 1994, Yes, it is time to consider use of a live-attenuated virus vaccine against HIV, J. NIH Res. 6:54,56-59.
11. Haynes, B.F., 1993, Scientific and social issues of human immunodeficiency virus vaccine development, Science 260:1279-1286.
12. McKinney, E.L., and Streilein, J.W., 1989, On the extraordinary capacity of allogeneic epidermal Langerhans cells to prime cytotoxic T cells in vivo, J. Immunol. 143:1560-1564.
13. Nair, S., Babu, J.S., Dunham, R.G., Kanda, P., Burke, R.L., and Rouse, B.T., 1993, Induction of primary, antiviral cytotoxic, and proliferative responses with antigens administered via dendritic cells, J. Virol. 67:4062-4069.
14. - cytolytic T lymphocytes, Nature 341:447-450.
15. - T lymphocytes to a microbial antigen, Nature 360:593-597.
16. Rabinovich, N.R., McInnes, P., Klein, D.L., and Hall, B.F., 1994, Vaccine technologies: view to the future, Science 265:1401-1404.
17. Reid, C.D.L., Fryer, P.R., Clifford, C., Kirk, A., Tikerpae, J., and Knight, S.C., 1990, Identification of hematopoietic progenitors of macrophages and dendritic Langerhans cells (DL-CFU) in human bone marrow and peripheral blood, Blood 76:1139-1149.
18. Sabin, A.B., 1992, Improbability of effective vaccination agaoinst human immunodeficiency virus because of its intracellular transmission and rectal portal of entry, Proc. Natl. Acad. Sci. USA 89:8852-8855.
19. Salk, J., Bretscher, P.A., Salk, P.L., Clerici, M. ,and Shearer, G.M., 1993, A strategy for prophylactic vaccination against AIDS, Science 260:1270-1272.
20. Schultz, M., Zinkernagel, R.M., and Hengartner, H., 1991, Peptide-induced antiviral protection by cytotoxic T cells, Proc. Natl. Acad. Sci. USA 88:991-993.
21. + cytotoxic T cells by imunization with purified HIV-1 envelope protein in ISCOMs, Nature 34:873-875.
22. Walker, C. Selby, M., Erickson, A., Do, D.C., Valensi, J-P., and Van Nest, G., 1992, Cationic lipids direct a viral glycoprotein into class I major histocompatibility complex antigen-presentation pathway, Proc. Natl. Acad. Sci. USA 89:7915-7918.